Page:United States Statutes at Large Volume 94 Part 3.djvu/540

 94 STAT. 3184

PUBLIC LAW 96-538—DEC. 17, 1980

"PART D—NATIONAL INSTITUTE OF ARTHRITIS, DIABETES, AND DIGESTIVE AND KIDNEY DISEASES, NATIONAL INSTITUTE OF NEUROLOGICAL DISEASES AND STROKE, AND OTHER INSTITUTES", Repeal.

SEC. 202. Section 431(c) (42 U.S.C. 289a(c)) is repealed. SEC. 203. (a) The heading of section 434 is amended to read as follows: NATIONAL INSTITUTE OF ARTHRITIS, DIABETES, AND DIGESTIVE AND KIDNEY DISEASES".

Comments and recommendations, transmittal to NIH. Subcommittees, establishment.

(b) Subsection (a) of section 434 (42 U.S.C. 289c-l(a)) is amended— (1) by striking out "National Institute of Arthritis, Metabolism, and Digestive Diseases" and inserting in lieu thereof "National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases"; (2) by striking out "National Arthritis, Metabolism, and Digestive Diseases Advisory Council" and inserting in lieu thereof "National Arthritis, Diabetes, and Digestive and Kidney Diseases Advisory Council"; and (3) by striking out the last sentence. (c) Section 434 is amended by striking out subsections (b) through (e) and inserting in lieu thereof the following: "(b) In the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases (hereinafter referred to in this section as the 'Institute') there shall be an Associate Director for Arthritis and Musculoskeletal and Skin Diseases, an Associate Director for Diabetes, Endocrinology, and Metabolic Diseases, an Associate Director for Digestive Diseases, and an Associate Director for Kidney, Urologic, and Hematologic Diseases who, under the supervision of the Director of the Institute, shall be responsible for— "(1) developing a coordinated plan (including recommendations for expenditures) for each of the national research institutes within the National Institutes of Health with respect to research and training concerning the diseases for which the positions of the Associate Direc^tors were created; "(2) assessing the adequacy of management approaches for the activities within such institutes concerning such diseases and developing improved approaches if needed; "(3) monitoring and reviewing expenditures by such institutes concerning such diseases; and "(4) identifying research opportunities concerning such diseases and recommending ways to utilize such opportunities. The Director of the Institute shall transmit to the Director of the National Institutes of Health the plans, recommendations, and reviews of the Associate Directors under paragraphs (1) through (4) together with such comments and recommendations as the Director of the Institute determines appropriate. "(c) There are established within the Advisory Council of the Institute a subcommittee on diabetes and endocrine and metabolic diseases, a subcommittee on arthritis and musculoskeletal and skin diseases, a subcommittee on digestive diseases, and a subcommittee on kidney, urologic, and hematologic diseases. The subcommittees shall be composed of members of the Advisory Council who are outstanding in the diagnosis, prevention, and treatment of the diseases for which the subcommittees are established and members of the Advisory Council who are leaders in the fields of education and public affairs. The subcommittees are authorized to review applications made to the Director for grants for research and training

�